J&J

U.S. FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost

The U.S. Food and Drug Administration authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson & Johnson, and said Americans can choose a different shot from their…

Read More Here

Johnson & Johnson says second shot boosts protection for moderate-severe COVID-19 to 94%

CHICAGO (Reuters) - Johnson & Johnson said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness to 94% in the United…

Read More Here

EU drug regulator EMA records 415 cases of possible rare blood clotting

The EU drug regulator said on Thursday it has received reports of 415 possible cases of rare blood clotting with a low platelet count in the European Economic Area, out…

Read More Here

Who and how is making use of AstraZeneca, J&J COVID vaccines

April 24 (Reuters) - Following is an outline of countries that have restricted or suspended use of COVID-19 vaccines from AstraZeneca and Johnson & Johnson, after Europe confirmed possible links…

Read More Here

UPDATE – EU regulator backs J&J shot, finds possible link to clots

April 20 (Reuters) - Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who received doses in the…

Read More Here

J&J COVID-19 vaccine reviewed for links to additional reports of severe side effects -CDC

April 19 (Reuters) - The United States is reviewing reports of a handful of potential cases of severe side effects among people who received Johnson & Johnson's COVID-19 vaccine in…

Read More Here

J&J scientists refute idea that COVID-19 vaccine’s design linked to clots

CHICAGO, April 16 (Reuters) - Scientists at Johnson & Johnson on Friday refuted an assertion in a major medical journal that the design of their COVID-19 vaccine, which is similar AstraZeneca's, may explain why both have been linked to…

Read More Here

No Causal Link Found So Far Between J&J’s Covid-19 Vaccine & Blood-Clot Cases, Company Researchers Say – WSJ

Johnson & Johnson said Friday there wasn’t enough evidence to establish that the company’s Covid-19 vaccine causes the rare blood-clotting condition that prompted U.S. health officials this week to recommend a…

Read More Here

Pfizer and Moderna decline request by J&J to study the risks of blood clots – WSJ

(Reuters) - Johnson & Johnson had reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots, but Pfizer Inc and Moderna…

Read More Here

Europe’s vaccine rollout hit by doubts over J&J, AstraZeneca shots

COPENHAGEN/ROME, April 14 (Reuters) - Europe's choppy vaccine rollout hit more trouble on Wednesday after U.S. drugmaker Johnson & Johnson delayed its COVID-19 shot and Denmark said it would drop…

Read More Here

Italy suspends distribution of J&J shots after use paused in U.S

ROME (Reuters) - Italy said on Wednesday it had suspended the use of some 184,000 shots of the Johnson & Johnson COVID-19 vaccine, after the brand delayed its introduction in…

Read More Here

J&J says delaying rollout of COVID-19 vaccine in Europe

(Reuters) - Johnson & Johnson said on Tuesday it would delay the rollout of its COVID-19 vaccine in Europe and was reviewing cases of extremely rare blood clots in people…

Read More Here

EMA gives green light to J&J’s single-shot COVID-19 vaccine

March 11 (Reuters) - The European Union's drugs regulator on Thursday recommended conditionally approving Johnson & Johnson's single dose COVID-19 vaccine, as the bloc seeks to speed up a stuttering…

Read More Here

J&J ‘under stress’ to meet EU second-quarter vaccine supply goal – source

BRUSSELS, March 9 (Reuters) - Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19…

Read More Here

Johnson & Johnson COVID-19 vaccine could be available in Europe in April – source

BRUSSELS (Reuters) - Johnson & Johnson could deliver the first doses of its COVID-19 vaccine to Europe in April, an EU official told Reuters on Wednesday after a top lawmaker…

Read More Here